The mechanism of chenodeoxycholic acid and its derivatives in hepatobiliary tumor
Chenodeoxycholic acid (CDCA) is a primary bile acid and is involved in the digestion, transportation, and absorption of nutriments in the hepatobiliary system. Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily. In vivo and in vitro studies have demonstrated that CDCA is the...
Main Author: | QI Fei |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2018-05-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=9073 |
Similar Items
-
PI3K/Akt/mTOR signaling pathway and malignant hepatobiliary tumors
by: CHEN Xuxiao
Published: (2015-06-01) -
Clinical value of circulating microRNAs in hepatic, biliary and pancreatic carcinomas
by: LIN Kun
Published: (2015-05-01) -
Updated key points and clinical pathway for NCCN clinical practice guidelines in oncology: hepatobiliary cancers (Version 2.2017)
by: YU Jiongjie, et al.
Published: (2017-11-01) -
Cerebrotendinous xanthomatosis‐associated diarrhea and response to chenodeoxycholic acid treatment
by: Eric P. Brass, et al.
Published: (2020-11-01) -
Paracellular/transcellular perturbations in hepatobiliary dysfuntion
by: Gilroy, Duncan J.
Published: (2013)